After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Piramal Enterprises is looking to sell some non-core businesses to boost capital. In June, the group agreed to sell a 20 percent stake in Piramal Pharma to Carlyle for $490 million.